Loading...
Prolonged Amphetamine Treatments Cause Long-Term Decrease of Dopamine Uptake in Cultured Cells
Amphetamine (AMPH) is a systemic stimulant used to treat a variety of diseases including Attention Deficit Hyperactive Disorder, narcolepsy and obesity. Previous data showed that by binding to catecholamine transporters, AMPH prevents the reuptake of the neurotransmitters dopamine (DA) and norepinep...
Saved in:
| Published in: | Neurochem Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer US
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7260268/ https://ncbi.nlm.nih.gov/pubmed/31883055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11064-019-02938-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|